Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25073,886,1.18 [1.07-1.32],0.0015981978928906
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25103,142,2.06 [1.62-2.62],4.428847014532385e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26659,152,1.08 [0.85-1.38],0.530306571180585
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19944,490,1.52 [1.32-1.75],8.836932079233546e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26599,92,1.11 [0.81-1.52],0.525780146813459
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25895,79,2.13 [1.58-2.86],6.530944659780414e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27621,91,1.11 [0.81-1.53],0.5075157971660234
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27642,64,0.98 [0.67-1.42],0.9039579778857312
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25340,46,1.39 [0.88-2.19],0.1577118592664009
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27109,108,1.93 [1.47-2.53],1.8277850464974693e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27069,68,2.18 [1.59-2.99],1.384852626589937e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27685,65,0.90 [0.63-1.30],0.589591277683773
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27644,97,0.91 [0.68-1.23],0.5394451460218923
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27635,88,0.85 [0.63-1.16],0.3132560347837886
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,27455,45,0.95 [0.61-1.47],0.8049626965415076
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26824,386,1.30 [1.11-1.52],0.0011181855409296
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26584,146,1.44 [1.12-1.84],0.0042398102314717
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26684,246,1.24 [1.02-1.51],0.0301180573321813
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24039,29,0.93 [0.53-1.62],0.7858496917505492
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24058,48,1.27 [0.81-1.98],0.2927064591144999
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24137,127,1.13 [0.86-1.49],0.3618997442561276
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24141,131,1.13 [0.86-1.47],0.388047989738677
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13496,290,1.08 [0.90-1.29],0.4200654390399296
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10831,27,1.06 [0.59-1.92],0.8463187532874722
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24057,47,1.00 [0.64-1.55],0.9989500656113944
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25594,804,1.18 [1.06-1.32],0.0031657718168218
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26629,197,1.12 [0.90-1.39],0.299858172528503
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27274,75,1.27 [0.89-1.80],0.188903118695121
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27758,73,1.12 [0.79-1.59],0.5353550157408268
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,27522,48,1.26 [0.81-1.96],0.2964729484626021
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27764,39,0.91 [0.57-1.46],0.7038437908243846
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Stomach,27804,32,0.70 [0.43-1.14],0.1562980431063652
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,27500,288,0.90 [0.76-1.07],0.2315161087475599
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27737,111,0.89 [0.68-1.18],0.4142771562842466
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27740,93,0.89 [0.66-1.21],0.4501108031913442
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27705,46,1.22 [0.78-1.91],0.379617502356441
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",27707,46,1.22 [0.78-1.91],0.3796492723965379
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,27602,248,1.00 [0.82-1.21],0.9740523479799946
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27767,110,1.12 [0.84-1.50],0.4293972266754652
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,27675,188,0.95 [0.77-1.19],0.6731669672557092
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of breast,15321,94,0.79 [0.59-1.05],0.1064875302809414
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,14961,685,0.98 [0.87-1.10],0.6861164499586009
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26793,196,1.18 [0.95-1.47],0.1339234126069591
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26688,347,1.15 [0.98-1.36],0.0890802311226188
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26688,347,1.15 [0.98-1.36],0.0890802311226188
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25466,359,1.20 [1.02-1.42],0.026236525961626
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27330,78,0.90 [0.65-1.26],0.5469378391056242
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27542,104,1.15 [0.85-1.55],0.3617167979068107
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24387,696,1.24 [1.10-1.39],0.0005285931693265
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26488,434,1.17 [1.01-1.36],0.0317317379980673
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26005,115,2.08 [1.62-2.69],1.608787839884575e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27047,53,2.03 [1.38-2.97],0.0003093820730765
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25990,100,2.13 [1.63-2.79],3.3125596226632055e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26222,332,1.70 [1.43-2.02],2.4794566228051302e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26212,322,1.73 [1.45-2.06],1.319708229886033e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25862,177,1.11 [0.86-1.43],0.4319038486574287
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25866,174,1.10 [0.85-1.42],0.4838957513956188
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24227,536,1.21 [1.06-1.39],0.0055773671756227
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23766,75,1.18 [0.83-1.69],0.3578079338183023
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24182,491,1.18 [1.02-1.36],0.0230259885569363
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23730,39,0.97 [0.60-1.56],0.8936355017284001
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23769,78,1.33 [0.94-1.88],0.1111715075744725
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,24124,766,1.16 [1.04-1.30],0.0095878021282701
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23650,292,1.43 [1.19-1.72],0.0001226146883794
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27364,223,1.35 [1.10-1.66],0.0046665750771561
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27435,159,1.52 [1.19-1.94],0.0007789541307435
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25822,83,1.29 [0.92-1.80],0.1424056384040535
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27690,83,1.23 [0.88-1.72],0.216262671755631
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23441,83,1.29 [0.92-1.81],0.1363844989306619
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Alcohol dependence,25833,94,1.66 [1.21-2.28],0.0015166389470187
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,25807,67,1.79 [1.23-2.62],0.0024340734069499
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23426,68,1.26 [0.87-1.84],0.2248091226608833
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23748,390,1.06 [0.91-1.24],0.4520975266803819
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression,26093,337,1.02 [0.86-1.20],0.8300981880813126
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression or dysthymia,23599,298,1.03 [0.86-1.22],0.7698673889242754
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23501,143,1.13 [0.88-1.46],0.3483150482993919
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Other anxiety disorders,26301,67,0.97 [0.67-1.39],0.8497428867219399
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,24737,1444,0.99 [0.91-1.08],0.855664837407939
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23062,162,0.78 [0.62-0.97],0.0264794197651992
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27600,130,0.70 [0.56-0.89],0.0033474565750214
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26486,489,1.07 [0.93-1.23],0.3419028330484337
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,26162,165,1.09 [0.86-1.39],0.4611854787540621
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,26100,103,1.17 [0.87-1.58],0.3067086521748037
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27445,93,1.20 [0.87-1.64],0.2669235076743602
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27318,38,0.79 [0.50-1.25],0.3093081319788493
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,26172,175,1.09 [0.86-1.37],0.4842672520191035
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,27199,136,1.22 [0.94-1.59],0.1413620910702772
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26684,618,0.99 [0.87-1.11],0.8240015484066647
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26205,139,0.90 [0.70-1.16],0.4176233612886675
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26397,331,0.97 [0.82-1.14],0.682249271917342
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27588,84,1.30 [0.94-1.81],0.1162962728359583
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,27557,53,1.34 [0.88-2.03],0.1719225786854331
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,27373,121,1.02 [0.77-1.34],0.9012451904325244
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27334,307,1.07 [0.90-1.28],0.4233024284980606
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27195,168,0.95 [0.76-1.20],0.6696569371614998
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27115,88,1.35 [0.98-1.87],0.0660457269097731
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27131,104,1.01 [0.76-1.36],0.9252983965581536
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27075,48,0.95 [0.62-1.45],0.7992065555056042
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26109,65,1.11 [0.76-1.61],0.5911063596523618
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26226,182,1.31 [1.04-1.63],0.0198279343397036
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27194,129,1.21 [0.92-1.58],0.1714254759591214
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27555,23,1.30 [0.69-2.46],0.4150237005644336
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1740,23,0.91 [0.47-1.76],0.7766968049432511
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25838,23,1.35 [0.71-2.56],0.3561594449471414
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27427,49,1.11 [0.72-1.71],0.629629726341239
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27406,28,0.97 [0.55-1.69],0.9062275014008913
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27335,92,0.78 [0.58-1.05],0.0992481657213486
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27385,96,1.14 [0.83-1.55],0.4190408767657417
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27685,120,1.17 [0.89-1.55],0.2616755366174982
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27281,89,1.33 [0.96-1.83],0.0816050356323923
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21775,1956,1.35 [1.25-1.46],2.6630448231160297e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27481,40,1.32 [0.82-2.13],0.2526732952949408
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22818,1293,1.33 [1.21-1.46],2.0743516776446702e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,22843,1318,1.34 [1.22-1.47],5.658983785411734e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21575,50,1.97 [1.30-2.97],0.00126295171302
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26307,569,1.24 [1.09-1.41],0.0014286756474348
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,26088,350,1.20 [1.01-1.41],0.0326459640807279
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27095,140,1.13 [0.88-1.47],0.3364905838355303
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27218,263,1.23 [1.02-1.48],0.0329372456681863
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27696,60,1.65 [1.12-2.42],0.0106383223599872
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25898,160,1.28 [1.00-1.62],0.0472941043476434
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26150,422,1.18 [1.02-1.37],0.030211470159749
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27290,80,1.09 [0.78-1.53],0.6166210553336429
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27280,170,1.30 [1.03-1.65],0.024653508789041
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27272,62,1.16 [0.79-1.71],0.4480343844372076
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27273,63,1.17 [0.80-1.71],0.4269461551750684
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21584,59,1.17 [0.78-1.75],0.4361319086698053
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25190,46,1.09 [0.70-1.70],0.7128292554026088
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,25217,73,1.29 [0.91-1.85],0.1578135271531729
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19020,93,1.41 [1.02-1.95],0.0381299670459449
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19117,190,1.59 [1.27-2.00],5.325391651476461e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,25185,41,1.45 [0.91-2.33],0.1200966062589678
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25205,61,1.60 [1.10-2.34],0.0134758550943776
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27298,119,1.22 [0.92-1.61],0.1667819567956199
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27272,110,1.21 [0.90-1.61],0.2003223041916665
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27305,83,1.17 [0.84-1.64],0.3472658062967505
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27352,72,1.09 [0.76-1.55],0.6385457167672222
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27069,49,0.95 [0.62-1.45],0.8066010705083163
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27101,81,1.71 [1.24-2.37],0.0010954175938513
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26587,111,1.49 [1.12-1.98],0.0057383869674928
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26568,92,1.60 [1.18-2.17],0.0026053398355039
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27639,87,1.56 [1.14-2.13],0.0058566391904766
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,26908,432,1.11 [0.95-1.28],0.1808845397355513
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,27066,55,1.26 [0.84-1.91],0.2667961040634443
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23525,1938,1.14 [1.06-1.23],0.0002692501904838
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27581,139,1.12 [0.87-1.45],0.3858951978897356
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26604,185,1.34 [1.07-1.68],0.0104460988792668
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26576,157,1.32 [1.04-1.69],0.0243000397480753
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27192,214,0.92 [0.75-1.12],0.4154815028407239
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27190,212,0.93 [0.76-1.14],0.4938412167761717
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26924,669,1.14 [1.02-1.29],0.0255763721364617
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,26350,95,1.29 [0.94-1.76],0.1113519428919084
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,26362,107,1.13 [0.84-1.52],0.4073341448021659
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26689,434,1.13 [0.98-1.31],0.1000277542323107
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,26486,231,1.12 [0.92-1.37],0.2717701770236134
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16015,51,0.88 [0.58-1.33],0.5362186565748628
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25440,873,1.08 [0.97-1.20],0.1539930948080468
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,27087,110,1.36 [1.02-1.83],0.038315625184271
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27087,110,1.36 [1.02-1.83],0.038315625184271
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27087,110,1.36 [1.02-1.83],0.038315625184271
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26041,793,1.04 [0.93-1.15],0.5246420868775856
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Asthma,21266,793,1.08 [0.97-1.21],0.1713375030683055
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21124,793,1.09 [0.97-1.21],0.1460439211544801
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21250,777,1.07 [0.95-1.19],0.251521087253457
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27614,56,1.63 [1.10-2.42],0.0144377080085569
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,26484,42,1.80 [1.16-2.80],0.0085399813713802
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27677,42,1.79 [1.15-2.79],0.0094375702977895
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26477,35,2.04 [1.30-3.20],0.0020026734972638
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,26462,75,1.18 [0.83-1.68],0.3487680864627491
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,26564,177,1.19 [0.94-1.49],0.1455950497923786
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26961,84,1.27 [0.91-1.77],0.1591625589655664
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19674,5099,1.13 [1.08-1.19],1.2408676147332206e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27185,486,0.96 [0.84-1.10],0.5646034176101897
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27734,140,1.12 [0.86-1.44],0.4026390882549518
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,27740,130,1.13 [0.87-1.47],0.3688840124275242
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,26817,118,1.04 [0.79-1.37],0.7884045023478461
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26805,106,1.08 [0.81-1.45],0.5979053996811277
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27719,156,1.01 [0.80-1.29],0.9217583309488236
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26791,92,0.95 [0.70-1.29],0.7461232950661842
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26539,64,1.08 [0.74-1.58],0.6771841464939441
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27682,44,0.99 [0.63-1.55],0.960517065827372
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22359,196,1.25 [1.00-1.56],0.0455317327230034
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23887,1724,1.17 [1.08-1.26],6.029547816542052e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,22433,270,1.25 [1.04-1.50],0.019202597337784
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22711,548,1.08 [0.95-1.23],0.2649772283126633
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22226,63,1.62 [1.12-2.33],0.010428078792875
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22292,129,1.37 [1.05-1.79],0.0213185055171762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22194,31,2.23 [1.45-3.41],0.0002331455124167
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,22260,97,1.12 [0.83-1.53],0.4569617624377191
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,22263,100,1.41 [1.04-1.90],0.0273551898597765
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27699,71,1.31 [0.91-1.87],0.1417422987287587
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,22261,98,1.30 [0.96-1.77],0.0923955121434544
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22796,633,1.19 [1.05-1.34],0.0068628813779694
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,27613,162,1.04 [0.82-1.32],0.754938945657107
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,22546,383,1.20 [1.03-1.41],0.0227038085109365
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22277,114,1.29 [0.97-1.71],0.0826111758420409
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27609,189,1.17 [0.94-1.46],0.1621157557554629
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,27576,125,1.04 [0.79-1.36],0.7924452154629678
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,25046,1160,1.10 [1.00-1.20],0.0466003947053071
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,24280,394,1.02 [0.88-1.19],0.7702627740018217
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,24006,120,1.19 [0.90-1.57],0.2199307258794534
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,23981,95,1.25 [0.91-1.70],0.1662121282288563
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24472,586,1.13 [1.00-1.28],0.057942974787411
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26921,740,1.23 [1.10-1.38],0.0004269328461404
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,22892,1654,1.15 [1.07-1.24],0.0003761245653151
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27470,72,2.06 [1.53-2.77],1.7466269688480383e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27720,103,2.07 [1.60-2.67],2.700583861108272e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,26284,103,2.11 [1.62-2.74],2.4833634403263792e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26260,79,2.44 [1.83-3.26],1.040012220007519e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27667,130,1.14 [0.87-1.49],0.3376190314930122
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,26311,130,1.15 [0.88-1.50],0.3111391799220182
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26293,112,1.18 [0.88-1.58],0.261660703765564
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26768,587,1.20 [1.05-1.36],0.0060957400219463
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26763,582,1.20 [1.06-1.37],0.0045475027634546
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21303,65,0.84 [0.59-1.21],0.3512847784567069
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal stricture,27463,65,0.83 [0.58-1.19],0.3164049838826325
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21283,45,1.20 [0.76-1.89],0.4249783327491263
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21540,302,1.20 [1.01-1.44],0.0401942961421149
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21411,173,0.98 [0.78-1.23],0.8613855099195835
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21486,248,1.26 [1.04-1.53],0.0182593007888412
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,26638,222,1.24 [1.01-1.53],0.0368378609694805
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27382,81,1.24 [0.88-1.73],0.216955161056618
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21417,179,1.09 [0.87-1.37],0.4459958044035563
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21326,88,1.60 [1.18-2.18],0.002726522770486
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22020,782,1.12 [1.01-1.25],0.0392148790558671
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,21424,186,1.42 [1.14-1.77],0.0019298310353029
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27369,68,1.12 [0.78-1.62],0.530804509883535
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,27068,118,2.27 [1.78-2.90],5.049898467133512e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,27013,63,1.93 [1.36-2.73],0.000199932798399
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26569,517,1.03 [0.90-1.18],0.6839494003623654
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,26458,406,1.02 [0.88-1.19],0.775039913994427
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,26129,77,1.19 [0.84-1.67],0.3330580764316508
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26098,46,1.14 [0.73-1.78],0.57281996002049
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,26115,63,1.41 [0.97-2.06],0.074967723423427
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27631,63,1.40 [0.96-2.05],0.0810445525523279
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26542,280,1.41 [1.17-1.69],0.0002226837409953
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26329,67,1.17 [0.80-1.69],0.4197384582134005
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,26314,52,1.28 [0.84-1.95],0.255142448745023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26301,39,1.19 [0.73-1.94],0.484806900036285
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26443,181,1.50 [1.20-1.87],0.0004317042965727
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,26438,176,1.54 [1.23-1.93],0.0001869027811899
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25223,1473,1.09 [1.01-1.18],0.0355967390540589
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27418,99,1.20 [0.88-1.63],0.2535069744991438
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27373,459,1.01 [0.88-1.16],0.8768417334352964
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26698,526,1.06 [0.93-1.21],0.3663516983776889
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27037,395,1.19 [1.02-1.39],0.0265150561572707
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26748,106,1.11 [0.83-1.49],0.4917685825526671
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26865,223,1.15 [0.94-1.41],0.1873624457541065
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27545,84,1.41 [1.02-1.96],0.0383607813864547
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27531,70,1.59 [1.12-2.26],0.0091434237031274
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27510,49,1.41 [0.92-2.17],0.1172758899863896
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27632,36,0.97 [0.59-1.59],0.9017399279846052
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27629,33,1.02 [0.61-1.72],0.9400577149695932
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26978,64,0.78 [0.55-1.11],0.1646265652424944
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27264,350,1.02 [0.87-1.20],0.7647065410743407
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26243,71,0.84 [0.60-1.19],0.3334746768872271
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26269,97,1.00 [0.74-1.36],0.984028905346763
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26253,81,1.04 [0.74-1.45],0.8354743221314859
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26377,205,0.98 [0.79-1.20],0.8285707326937257
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26349,177,1.03 [0.82-1.29],0.8177633849793382
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21520,3491,1.08 [1.02-1.14],0.0099885123613737
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23123,1847,1.15 [1.07-1.24],0.0002411695341873
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25382,1102,1.02 [0.93-1.12],0.6900309071177078
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21394,118,1.38 [1.05-1.83],0.0228529632952003
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21614,338,1.35 [1.14-1.59],0.0005367431891176
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27465,112,1.33 [1.00-1.78],0.0492856986394231
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27482,100,1.47 [1.09-1.99],0.0115476293691808
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21928,652,1.18 [1.04-1.33],0.0091390712081162
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24508,652,1.16 [1.03-1.31],0.0136322093841971
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21322,46,1.52 [0.97-2.38],0.0662230631572472
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27415,45,1.64 [1.07-2.51],0.023426562068346
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21426,150,1.20 [0.93-1.54],0.1566979231178389
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21300,24,0.74 [0.42-1.32],0.3134365380834655
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21400,124,1.39 [1.05-1.83],0.0192213449760308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27694,61,1.26 [0.86-1.86],0.2354461903279742
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21601,325,1.15 [0.97-1.37],0.1007982704508429
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21498,222,1.12 [0.91-1.38],0.2754139023683117
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22508,1232,1.12 [1.03-1.23],0.010828785147389
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21313,37,1.05 [0.64-1.72],0.844878309293556
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21451,175,1.01 [0.81-1.27],0.9010267652262602
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21311,35,nan [nan-nan],
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21306,30,0.96 [0.56-1.65],0.8956031670352023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21795,519,1.10 [0.96-1.26],0.1651119783988821
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21707,431,1.08 [0.93-1.25],0.3287954082429918
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21999,279,1.29 [1.07-1.55],0.0074759045479019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27413,151,1.26 [0.98-1.61],0.0703609821877609
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27302,40,1.25 [0.77-2.02],0.3695821545276524
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24843,46,1.20 [0.77-1.88],0.4189900907667248
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25014,217,0.86 [0.71-1.05],0.1495733597060019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25693,896,0.91 [0.82-1.00],0.0509934780680402
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24933,136,0.83 [0.65-1.06],0.1381542924982344
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24853,56,0.95 [0.64-1.42],0.8114038747271618
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25553,756,0.91 [0.82-1.02],0.1052787324790397
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24856,59,0.89 [0.61-1.31],0.5553686425926108
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25047,250,0.88 [0.73-1.06],0.1778448594696842
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24911,114,0.89 [0.68-1.17],0.4124412668089278
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24869,72,0.95 [0.67-1.35],0.7910597856016566
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24944,147,1.01 [0.79-1.29],0.9628927127093484
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24862,65,0.94 [0.65-1.36],0.7432637030078306
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25122,325,0.95 [0.81-1.13],0.5734019752979855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24565,285,1.10 [0.92-1.32],0.2834810288173138
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24332,52,1.56 [1.03-2.35],0.0354757905925953
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24334,54,0.95 [0.63-1.42],0.7839227437942162
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24397,117,0.92 [0.70-1.21],0.559504678684956
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24337,57,0.84 [0.57-1.24],0.3816482653776065
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24345,65,1.03 [0.71-1.49],0.8733932049119332
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24329,49,0.85 [0.56-1.27],0.4183049679100372
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24507,227,0.97 [0.79-1.18],0.7370322170824416
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24329,49,0.96 [0.63-1.47],0.8466790666870019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24334,54,0.93 [0.62-1.39],0.7120236610952941
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24389,109,0.95 [0.72-1.27],0.7485736744277844
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24351,71,1.03 [0.72-1.48],0.8566285582497302
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24707,427,0.97 [0.84-1.12],0.6776923807537601
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24424,144,1.17 [0.91-1.51],0.2153981063863161
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24497,217,0.93 [0.76-1.14],0.4879150985606234
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26428,97,1.21 [0.89-1.66],0.2215180378689645
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26667,336,1.19 [1.00-1.41],0.0446363523022246
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26389,58,1.51 [1.03-2.23],0.0368993146122727
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26398,67,0.86 [0.60-1.23],0.4008276224649159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26445,114,1.02 [0.77-1.35],0.8969246737405627
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23501,4350,0.97 [0.93-1.03],0.3247743267598442
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11291,410,1.12 [0.96-1.31],0.1358801068055537
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26271,210,1.60 [1.30-1.97],1.13445812222573e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26116,55,1.26 [0.83-1.92],0.2707639977940158
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26418,43,1.57 [0.99-2.50],0.0574646212488134
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26423,48,2.30 [1.61-3.29],5.077712519810032e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26429,54,2.32 [1.66-3.24],7.822029864261152e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27432,243,1.13 [0.93-1.37],0.2299241717593391
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27497,54,0.95 [0.63-1.42],0.7902084503446751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27358,169,1.13 [0.89-1.42],0.3220781483241159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27282,93,0.99 [0.73-1.35],0.9570157045094096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26293,870,1.08 [0.97-1.20],0.1605684241953089
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,25505,82,0.94 [0.68-1.30],0.7098380169722396
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25489,66,1.30 [0.89-1.89],0.1690818925311831
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25604,181,1.37 [1.09-1.72],0.0063704914256768
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25508,85,0.94 [0.68-1.30],0.7075315367448238
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26031,608,1.06 [0.94-1.20],0.351386343278411
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10953,72,1.16 [0.81-1.67],0.42417648810908
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10917,36,1.11 [0.66-1.87],0.6852534281559762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,10919,38,1.30 [0.79-2.13],0.3041186867933487
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10970,89,1.46 [1.06-2.00],0.0201200873938491
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10946,65,1.23 [0.84-1.81],0.2783005042027553
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10985,104,1.15 [0.85-1.55],0.3748837891531966
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15171,247,0.92 [0.76-1.11],0.3991319608442967
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14996,72,1.07 [0.75-1.54],0.6940288844023553
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15013,89,1.07 [0.78-1.48],0.6607937243749906
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14978,54,0.82 [0.56-1.20],0.2984299848708477
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15137,382,1.07 [0.91-1.25],0.4249191335656965
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,14837,82,1.25 [0.89-1.75],0.2007925870203855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14940,185,1.02 [0.82-1.28],0.8396075926441767
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13959,2733,1.00 [0.94-1.07],0.9920525252047844
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,11519,293,1.08 [0.91-1.30],0.3774680634610668
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11316,90,0.92 [0.68-1.26],0.6169695941448912
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11339,113,1.13 [0.85-1.50],0.4151243213144115
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11524,298,0.96 [0.80-1.14],0.6155966076161424
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11522,296,1.04 [0.87-1.24],0.6953886480901429
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11693,467,0.96 [0.84-1.11],0.6097521324479687
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11392,166,1.01 [0.80-1.27],0.9291813134632796
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11441,215,1.24 [1.01-1.53],0.0432762655479076
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11307,81,1.30 [0.93-1.83],0.1303543862309879
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11364,138,1.00 [0.78-1.30],0.9753827071162464
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15323,199,1.04 [0.84-1.29],0.7128387269421521
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15332,190,1.04 [0.84-1.30],0.7103562689986169
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15352,108,0.94 [0.71-1.26],0.6905564178237851
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15344,118,0.97 [0.73-1.27],0.8006832524305592
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11298,72,0.90 [0.64-1.27],0.5635373172805999
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11288,62,0.80 [0.56-1.14],0.2111717985966235
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11301,75,0.91 [0.65-1.27],0.5749207138962429
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,15245,373,1.15 [0.98-1.35],0.0839561124801731
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12352,1126,1.05 [0.96-1.16],0.2727982835932266
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11998,772,1.01 [0.90-1.13],0.8362750385514418
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15330,154,1.07 [0.84-1.36],0.6009319252530159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11575,349,0.93 [0.79-1.09],0.3776323040911729
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11498,272,1.10 [0.91-1.33],0.3126703997288889
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11487,261,1.20 [0.99-1.45],0.0588190820887648
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female infertility,11337,111,0.95 [0.72-1.27],0.7416722999465019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11330,104,1.00 [0.74-1.35],0.9895326171312216
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15349,867,1.11 [0.99-1.24],0.0870108334043236
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15352,1182,1.10 [1.00-1.22],0.0590237688231261
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15349,473,1.03 [0.89-1.19],0.6763526797981927
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15011,135,1.02 [0.78-1.33],0.8796532589044282
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15064,188,1.20 [0.96-1.51],0.1149456109919714
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15041,165,0.84 [0.67-1.05],0.1302027466385732
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15366,167,0.80 [0.64-1.01],0.0608791064141518
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15368,164,0.79 [0.63-0.99],0.0415490718378686
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15363,409,1.17 [1.00-1.37],0.0550250511801447
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15078,124,1.06 [0.80-1.40],0.7065684613920551
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15179,225,1.25 [1.01-1.54],0.0416111399650644
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14631,149,0.96 [0.75-1.23],0.7471054376454639
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14680,198,0.94 [0.75-1.17],0.5726573478453116
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14733,251,1.10 [0.90-1.34],0.3637925744305367
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14627,145,1.70 [1.31-2.23],8.984750091187705e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14619,137,1.05 [0.81-1.37],0.711983238027174
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14628,146,0.96 [0.75-1.24],0.7696768215859509
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14399,229,0.93 [0.75-1.14],0.4700415748592444
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14603,433,1.05 [0.90-1.23],0.5156682479171458
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14831,661,1.15 [1.01-1.31],0.041646728916417
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15368,168,1.04 [0.82-1.32],0.7550065637557077
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13936,127,1.06 [0.80-1.40],0.6985372196350257
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14272,102,1.32 [0.96-1.82],0.0835665052683396
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15375,333,1.07 [0.90-1.27],0.457041156898446
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15296,254,1.07 [0.88-1.31],0.4757958720402206
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15363,250,0.86 [0.71-1.04],0.1198833903493465
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15354,241,0.86 [0.71-1.04],0.126728600080324
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27559,37,1.01 [0.62-1.65],0.9653063642652516
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26158,524,1.13 [0.99-1.30],0.0638766007613786
